share_log

Exelixis' (NASDAQ:EXEL) 23% Return Outpaced the Company's Earnings Growth Over the Same One-year Period

Exelixis' (NASDAQ:EXEL) 23% Return Outpaced the Company's Earnings Growth Over the Same One-year Period

Exelixis(納斯達克股票代碼:EXEL)23%的回報率超過了公司同期的收益增長
Simply Wall St ·  02/26 07:28

We believe investing is smart because history shows that stock markets go higher in the long term. But if you choose that path, you're going to buy some stocks that fall short of the market. Over the last year the Exelixis, Inc. (NASDAQ:EXEL) share price is up 23%, but that's less than the broader market return. Zooming out, the stock is actually down 3.5% in the last three years.

我們認爲投資是明智之舉,因爲歷史表明,從長遠來看,股市會走高。但是,如果你選擇這條道路,你將買入一些不符合市場的股票。去年,Exelixis公司(納斯達克股票代碼:EXEL)的股價上漲了23%,但低於整個市場的回報率。放大,股票實際上是 向下 在過去三年中爲3.5%。

Since the stock has added US$318m to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

由於該股僅在過去一週的市值就增加了3.18億美元,因此讓我們看看基礎表現是否推動了長期回報。

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

雖然市場是一種強大的定價機制,但股價反映了投資者的情緒,而不僅僅是潛在的業務表現。考慮市場對公司的看法發生了怎樣的變化的一種不完美但簡單的方法是將每股收益(EPS)的變化與股價走勢進行比較。

During the last year Exelixis grew its earnings per share (EPS) by 15%. This EPS growth is significantly lower than the 23% increase in the share price. So it's fair to assume the market has a higher opinion of the business than it a year ago.

去年,Exelixis的每股收益(EPS)增長了15%。每股收益的增長明顯低於股價23%的漲幅。因此,可以公平地假設市場對該業務的看法比一年前更高。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何隨着時間的推移而變化的(點擊圖片發現確切的值)。

earnings-per-share-growth
NasdaqGS:EXEL Earnings Per Share Growth February 26th 2024
納斯達克GS:EXEL每股收益增長 2024年2月26日

We know that Exelixis has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

我們知道Exelixis最近提高了利潤,但是它會增加收入嗎?這份顯示分析師收入預測的免費報告應幫助您弄清楚每股收益的增長是否可以持續。

A Different Perspective

不同的視角

Exelixis shareholders are up 23% for the year. But that return falls short of the market. But at least that's still a gain! Over five years the TSR has been a reduction of 0.9% per year, over five years. So this might be a sign the business has turned its fortunes around. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.

Exelixis的股東今年增長了23%。但是這種回報不及市場。但至少這還是個好處!在過去的五年中,股東總回報率在五年內每年下降0.9%。因此,這可能表明該企業已經扭轉了命運。大多數投資者花時間檢查內幕交易數據。你可以點擊這裏查看內部人士是否在買入或賣出。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

如果你想與管理層一起購買股票,那麼你可能會喜歡這份免費的公司名單。(提示:業內人士一直在購買它們)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論